Syndax Pharmaceuticals, Inc. (SNDX) Q2 FY25 Earnings Call

Q2 FY25 results, source: company transcript and SEC filings
QuarterQ2 FY25
Call date2025-08-05
Length74 minutes
EPS$-0.83
Revenue$38.0M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q4 FY25

All SNDX earnings · Back to SNDX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.